Cargando…
Multi-omics profiling reveals potential alterations in rheumatoid arthritis with different disease activity levels
BACKGROUND: Rheumatoid arthritis (RA) is a chronic, systemic autoimmune inflammatory disease, the pathogenesis of which is not clear. Clinical remission, or decreased disease activity, is the aim of treatment for RA. However, our understanding of disease activity is inadequate, and clinical remissio...
Autores principales: | Chen, Jianghua, Li, Shilin, Zhu, Jing, Su, Wei, Jian, Congcong, Zhang, Jie, Wu, Jianhong, Wang, Tingting, Zhang, Weihua, Zeng, Fanwei, Chang, Shengjia, Jia, Lihua, Su, Jiang, Zhao, Yi, Wang, Jing, Zeng, Fanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155393/ https://www.ncbi.nlm.nih.gov/pubmed/37138305 http://dx.doi.org/10.1186/s13075-023-03049-z |
Ejemplares similares
-
The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis
por: Zhu, Jing, et al.
Publicado: (2022) -
The Role of Vitamin D in Combination Treatment for Patients With Rheumatoid Arthritis
por: Wu, Jianhong, et al.
Publicado: (2020) -
Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study
por: Deng, Daihua, et al.
Publicado: (2020) -
The treatment and rehabilitation of a critical COVID‐19 case in China
por: Zheng, Xiangde, et al.
Publicado: (2020) -
Integrative network fusion-based multi-omics study for biomarker identification and patient classification of rheumatoid arthritis
por: Ding, Zihe, et al.
Publicado: (2023)